GSK plc

Q2 2026 13F-HR Holdings

Location
London, X0
Holdings as of
6/30/2026
Date filed
8/13/2026
Form type
13F-HR
Num holdings
13
Total value ($000)
$602,220
Net value change ($000)
+3,067 (0.5%)
New positions
0
Sold out positions
0
Turnover %
0.0%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/14/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
CRSP 22,448 14.7%
VIR 10,517 13.7%
CYTK 6,564 29.3%
IDYA 5,266 11.9%
BNTX 3,710 4.7%
NKTX 2,269 34.1%
RGNX 977 42.9%
Top Reduces (Value $000, Stocks/ETFs)
WAVE LIFE SCIENCES LTD -26,274 -19.9%
LYEL -9,091 -30.0%
FULC -7,160 -52.3%
CVRX -4,353 -45.7%
SPRO -1,195 -5.6%
BCYC -612 -8.6%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type